Increased maternal serum aquaporin 9 levels in pregnancies complicated with gestational diabetes mellitus
dc.authorid | Kaya, Serdar/0000-0002-4092-7316 | |
dc.authorid | sezer, salim/0000-0003-1287-4306 | |
dc.contributor.author | Sezer, Salim | |
dc.contributor.author | Kaya, Serdar | |
dc.contributor.author | Behram, Mustafa | |
dc.contributor.author | Dag, Ismail | |
dc.date.accessioned | 2025-03-26T17:34:58Z | |
dc.date.available | 2025-03-26T17:34:58Z | |
dc.date.issued | 2022 | |
dc.department | İstanbul Esenyurt Üniversitesi | |
dc.description.abstract | Introduction This study aimed to examine maternal serum aquaporin 9 levels in pregnant women with gestational diabetes mellitus and to compare them with non-diabetic pregnant women. Methods Forty-one pregnant women between 37 and 39 weeks of gestation complicated with gestational diabetes mellitus and 39 non-diabetic pregnant women at similar gestational weeks without additional obstetric complications were included in this cross-sectional study. Maternal serum aquaporin 9 levels and leptin levels of the cases were measured. Results Maternal serum leptin and aquaporin 9 levels in pregnant women with GDM were found to be significantly higher than in the control group (p < .001). In the study group, first-minute Apgar scores were significantly lower and birth weight significantly higher (p = .001 and .005, respectively). A weak but significant positive correlation between aquaporin 9 levels and maternal body mass index (r = 0.279, p = .012), birth weight (r = 0.433, p < .001), and hemoglobin A1c (r = 0.354, p = .001) levels was detected. A significant positive correlation was detected between maternal serum aquaporin 9 levels and leptin levels (r = 0.331, p = .003). Conclusion The increased aquaporin 9 levels detected in cases with gestational diabetes mellitus might be a marker of the poor maternal metabolic environment specific to diabetes and might contribute to the pathophysiology of gestational diabetes. | |
dc.identifier.doi | 10.1080/14767058.2021.1970131 | |
dc.identifier.endpage | 23 | |
dc.identifier.issn | 1476-7058 | |
dc.identifier.issn | 1476-4954 | |
dc.identifier.issue | 1 | |
dc.identifier.pmid | 34470136 | |
dc.identifier.scopus | 2-s2.0-85113740824 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 18 | |
dc.identifier.uri | https://doi.org/10.1080/14767058.2021.1970131 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14704/975 | |
dc.identifier.volume | 35 | |
dc.identifier.wos | WOS:000690835700001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Ltd | |
dc.relation.ispartof | Journal of Maternal-Fetal & Neonatal Medicine | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WOS_20250326 | |
dc.subject | Aquaporin 9; gestational diabetes mellitus; perinatal outcome; maternal metabolism; aquaglyceroporins | |
dc.title | Increased maternal serum aquaporin 9 levels in pregnancies complicated with gestational diabetes mellitus | |
dc.type | Article |